X Shen, Y Xia, H Lu, P Zheng, J Wang, Y Chen… - Biomedicine & …, 2024 - Elsevier
Abstract Thioredoxin reductase 1 (TrxR1) has emerged as a promising target for cancer
therapy. In our previous research, we discovered several new TrxR1 inhibitors and found …